BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 31330170)

  • 1. The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery.
    Reverter E; Cirera I; Albillos A; Debernardi-Venon W; Abraldes JG; Llop E; Flores A; Martínez-Palli G; Blasi A; Martínez J; Turon F; García-Valdecasas JC; Berzigotti A; de Lacy AM; Fuster J; Hernández-Gea V; Bosch J; García-Pagán JC
    J Hepatol; 2019 Nov; 71(5):942-950. PubMed ID: 31330170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension.
    Berzigotti A; Rossi V; Tiani C; Pierpaoli L; Zappoli P; Riili A; Serra C; Andreone P; Morelli MC; Golfieri R; Rossi C; Magalotti D; Zoli M
    J Gastroenterol; 2011 May; 46(5):687-95. PubMed ID: 21213113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
    Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.
    Turco L; Garcia-Tsao G; Magnani I; Bianchini M; Costetti M; Caporali C; Colopi S; Simonini E; De Maria N; Banchelli F; Rossi R; Villa E; Schepis F
    J Hepatol; 2018 May; 68(5):949-958. PubMed ID: 29331339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.
    Lens S; Alvarado-Tapias E; Mariño Z; Londoño MC; LLop E; Martinez J; Fortea JI; Ibañez L; Ariza X; Baiges A; Gallego A; Bañares R; Puente A; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; Forns X; García-Pagán JC
    Gastroenterology; 2017 Nov; 153(5):1273-1283.e1. PubMed ID: 28734831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg.
    Jindal A; Bhardwaj A; Kumar G; Sarin SK
    Am J Gastroenterol; 2020 Oct; 115(10):1624-1633. PubMed ID: 32453061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
    Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
    World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.
    Garcia-Tsao G; Bosch J; Kayali Z; Harrison SA; Abdelmalek MF; Lawitz E; Satapathy SK; Ghabril M; Shiffman ML; Younes ZH; Thuluvath PJ; Berzigotti A; Albillos A; Robinson JM; Hagerty DT; Chan JL; Sanyal AJ;
    J Hepatol; 2020 May; 72(5):885-895. PubMed ID: 31870950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Value of Hepatic Venous Pressure Gradient for Graft Hemodynamics in Living Donor Liver Transplantation.
    Matsushima H; Fujiki M; Sasaki K; Rotroff DM; Sands M; Bayona Molano MDP; Aucejo F; Diago Uso T; Eghtesad B; Miller C; Quintini C; Hashimoto K
    Liver Transpl; 2019 Jul; 25(7):1034-1042. PubMed ID: 30980599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.
    Azoulay D; Ramos E; Casellas-Robert M; Salloum C; Lladó L; Nadler R; Busquets J; Caula-Freixa C; Mils K; Lopez-Ben S; Figueras J; Lim C
    JHEP Rep; 2021 Feb; 3(1):100190. PubMed ID: 33294830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.
    Afdhal N; Everson GT; Calleja JL; McCaughan GW; Bosch J; Brainard DM; McHutchison JG; De-Oertel S; An D; Charlton M; Reddy KR; Asselah T; Gane E; Curry MP; Forns X
    J Viral Hepat; 2017 Oct; 24(10):823-831. PubMed ID: 28295923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients.
    Kim TY; Suk KT; Jeong SW; Ryu T; Kim DJ; Baik SK; Sohn JH; Jeong WK; Choi E; Jang JY; Kim MY
    J Korean Med Sci; 2019 Aug; 34(33):e223. PubMed ID: 31436052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis.
    Hofer BS; Simbrunner B; Hartl L; Jachs M; Bauer DJM; Balcar L; Paternostro R; Schwabl P; Semmler G; Scheiner B; Staettermayer AF; Trauner M; Mandorfer M; Reiberger T
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2308-2317.e7. PubMed ID: 36481475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipopenia correlates with higher portal pressure in patients with cirrhosis.
    Rodrigues SG; Brabandt B; Stirnimann G; Maurer MH; Berzigotti A
    Liver Int; 2019 Sep; 39(9):1672-1681. PubMed ID: 31207018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score.
    Kang SH; Jeong WK; Baik SK; Cha SH; Kim MY
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):860-870. PubMed ID: 30371017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
    Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
    Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease.
    Bassegoda O; Olivas P; Turco L; Mandorfer M; Serra-Burriel M; Tellez L; Kwanten W; Laroyenne A; Farcau O; Alvarado E; Moga L; Vuille-Lessard E; Fortea JI; Ibañez L; Tosetti G; Vanwolleghem T; Larrue H; Burgos-Santamaría D; Stefanescu H; Paternostro R; Cippitelli A; Lens S; Augustin S; Llop E; Laleman W; Trebicka J; Chang J; Masnou H; Zipprich A; Miceli F; Semmler G; Forns X; Primignani M; Bañares R; Puente A; Berzigotti A; Rautou PE; Villanueva C; Ginès P; Garcia-Pagan JC; Procopet B; Bureau C; Albillos A; Francque S; Reiberger T; Schepis F; Graupera I; Hernandez-Gea V
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2276-2286.e6. PubMed ID: 34688952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma.
    Cucchetti A; Cescon M; Golfieri R; Piscaglia F; Renzulli M; Neri F; Cappelli A; Mazzotti F; Mosconi C; Colecchia A; Ercolani G; Pinna AD
    J Hepatol; 2016 Jan; 64(1):79-86. PubMed ID: 26325538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.